CORRIGENDUM
In the article entitled, "Rabbit Syndrome-An acute complication of Neuroleptic Medication" , published in the July, 2001 issue of Indian Journal of Psychiatry ,the name of S.C.Bhargava co-author was left out inadvertently. The authors are Sujata Sethi & S.C.Bhargava. SUJATA SETHI', MD, Lecturer & S.C. BHARGAVA MD. Associate Professor,Department of Psychiatry, PtB.D. Sharma Postgraduate Institute of Medical Sciences, Rohtak-124001 Haryana(lndia) ('122/8, Shivaji Colony, Rohtak-124001 
Editor

NOTES & NEWS NEW RESEARCH FUNDS AVAILABLE FOR TREATMENT TRIALS FOR SCHIZOPHRENIA AND BIPOLAR DISORDER
The Stanley Foundation announces the availability of $10-$15 million per year in new funds specifically designated to support clinical trials for schizophrenia or bipolar disorder The Foundation will support studies on compounds in development, studies on the off-label use of existing compounds, and studies of novel and indigenous compounds that may be of benifit for these disorders. A variety of study designs will be considered, including adjunctive trials, uncontrolled pilot trials, and randomized controlled trials. Trials may be from single site or from multiple collaborating sites. A complete list of drug trials currently being supported by the Foundation is available at www Stanley research org.
Funding for the trials may range from $50,000 up to $ 300,000 per year for up to three years depending on the design Indirect costs can be paid up to 15 percent as part of the total grant Submissions will be reviewed by a scientific advisory board Application can be submitted online at www. 
